Not Possible To Specify clinical trials

Explore recruiting not possible to specify clinical trials.

Also recruiting in Europe

Not Possible To Specify trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Single center, decentralized, parallel group, open, non-randomized, long-term safety follow-up, and exploratory study of long-term effects on inflammatory, immunological, and aging related biomarkers in study participants treated with MSCs.

Sweden

Phase III and phase IV (Integrated) EU CTIS Study details

An adaptive, randomized, double-blind, single-center, placebo-controlled first-in-human study evaluating safety, tolerability and exposure of single and multiple ascending doses of Lactobacillus expressing CXCL12 administered topically to experimentally induced skin wounds

Sweden

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Clinical validation study of urinary clusterin and EGF in patients with chronic kidney disease

Italy, Denmark, Spain, Sweden, Germany

Therapeutic use (Phase IV) EU CTIS Study details

Evaluation of bioequivalence of two products containing 400 mg ibuprofen and 100 mg caffeine: Ibuprofen / Caffeine 400 mg / 100 mg coated granules (Test) vs. Thomapyrin TENSION DUO, 400mg / 100mg Filmtabletten (Reference). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy volunteers

Bulgaria

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Bioequivalence of Lenvatinib 10 mg Capsules versus Lenvima® 10 mg Capsules in Healthy Participants Under Fasting Conditions.

Portugal

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Study of exposure to substances prohibited by the World Anti-Doping Agency in healthy volunteers (ESPAMA_3). Proof of concept

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

Not Possible To Specify trials by city